Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis

• Main Authors: Hari Baskar Balasubramanian (Author), Sima Biswas (Author), Maria Talmon (Author), Filippo Patrucco (Author), Piero Emilio Balbo (Author), Luigia Grazia Fresu (Author), Angshuman Bagchi (Author)
• Format: Book
• Published: Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Idiopathic pulmonary fibrosis (IPF) is a progressive disease due to aggregation of fibroblasts on lung parenchyma. Nintedanib, an indolinone-derived tyrosine kinase inhibitor (TKi) has been approved for the treatment of IPF and it is a well-known inhibitor of platelet-derived growth factor (PDGF) re...